We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+7.72%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$3.14B
AUM Growth
+$178M
Cap. Flow
-$28.9M
Cap. Flow %
-0.92%
Top 10 Hldgs %
27.66%
Holding
502
New
39
Increased
154
Reduced
177
Closed
19

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$7.91M
2
AAPL icon
Apple
AAPL
+$5.57M
3
NOW icon
ServiceNow
NOW
+$4.84M
4
SBAC icon
SBA Communications
SBAC
+$1.43M
5
CVX icon
Chevron
CVX
+$863K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$14.9M
2
OXY icon
Occidental Petroleum
OXY
+$7.57M
3
FAST icon
Fastenal
FAST
+$4.54M
4
IBM icon
IBM
IBM
+$3.34M
5
MSFT icon
Microsoft
MSFT
+$2.82M

Sector Composition

Rank Sector Weight
1 Technology 15.71%
2 Healthcare 15.32%
3 Financials 13.99%
4 Industrials 9.68%
5 Consumer Staples 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLB icon
201
Core Laboratories
CLB
$518M
$1.02M 0.03%
27,170
+1,247
+5% +$56K
ROST icon
202
Ross Stores
ROST
$78.1B
$974K 0.03%
8,369
CBOE icon
203
Cboe Global Markets
CBOE
$30.2B
$942K 0.03%
7,847
CHTR icon
204
Charter Communications
CHTR
$15.7B
$927K 0.03%
1,912
+568
+42% +$261K
VYM icon
205
Vanguard High Dividend Yield ETF
VYM
$81.3B
$918K 0.03%
9,796
TXN icon
206
Texas Instruments
TXN
$255B
$914K 0.03%
7,127
+1,514
+27% +$187K
SHY icon
207
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$905K 0.03%
10,693
-225
-2% -$19.1K
ZBH icon
208
Zimmer Biomet
ZBH
$17.8B
$893K 0.03%
6,144
IWD icon
209
iShares Russell 1000 Value ETF
IWD
$81.5B
$885K 0.03%
6,485
+778
+14% +$103K
VEA icon
210
Vanguard FTSE Developed Markets ETF
VEA
$227B
$873K 0.03%
19,809
+4,828
+32% +$206K
JCI icon
211
Johnson Controls International
JCI
$87.5B
$870K 0.03%
21,375
-3,486
-14% -$147K
BP icon
212
BP
BP
$109B
$827K 0.03%
21,914
-6,053
-22% -$230K
IVE icon
213
iShares S&P 500 Value ETF
IVE
$49.1B
$820K 0.03%
6,301
-8
-0.1% -$995
ALC icon
214
Alcon
ALC
$32.8B
$811K 0.03%
14,328
-1,686
-11% -$96.6K
DAL icon
215
Delta Air Lines
DAL
$57B
$803K 0.03%
13,725
SO icon
216
Southern Company
SO
$109B
$768K 0.02%
12,054
-518
-4% -$32.1K
VSS icon
217
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
$764K 0.02%
6,875
-100
-1% -$10.7K
ED icon
218
Consolidated Edison
ED
$41.1B
$758K 0.02%
8,381
GLD icon
219
SPDR Gold Trust
GLD
$132B
$755K 0.02%
5,282
+115
+2% +$16.1K
DOV icon
220
Dover
DOV
$27.7B
$749K 0.02%
6,500
ETR icon
221
Entergy
ETR
$53.1B
$747K 0.02%
12,470
BXP icon
222
Boston Properties
BXP
$11B
$744K 0.02%
5,400
CP icon
223
Canadian Pacific Kansas City
CP
$81.1B
$733K 0.02%
14,375
EXAS
224
DELISTED
Exact Sciences
EXAS
$729K 0.02%
7,881
-412
-5% -$36.2K
LAZ icon
225
Lazard
LAZ
$4.23B
$727K 0.02%
18,196
-2,555
-12% -$96.5K

Similar funds

Gofen & Glossberg's Q4 2019 Portfolio in Review

As of Q4 2019, Gofen & Glossberg held 502 positions worth $3.14B, up 6% from $2.97B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Gofen & Glossberg's Q4 2019 filing shows 39 new, 154 increased, 177 reduced and 19 closed positions. Its largest new stake was SBA Communications: 6,040 shares worth $1.46M. The largest sale was Celgene Corp, an estimated $14.9M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q4 2019 buy was SBA Communications: 6,040 shares worth $1.46M.
  • Gofen & Glossberg added most to Bristol-Myers Squibb in Q4 2019, an estimated $7.91M increase.
  • Gofen & Glossberg's biggest Q4 2019 reduction was Occidental Petroleum, cutting an estimated $7.57M.
  • Gofen & Glossberg fully exited Celgene Corp in Q4 2019, selling an estimated $14.9M.
  • Gofen & Glossberg's ten largest holdings make up 28% of its $3.14B portfolio in Q4 2019.
  • Gofen & Glossberg opened 39 new positions and closed 19 in Q4 2019.
  • Gofen & Glossberg's portfolio value rose 6% quarter-over-quarter to $3.14B.

Based on Gofen & Glossberg's 13F filing for Q4 2019, filed 28 Jan 2020.